Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

MediciNova completes enrolment for phase 2 clinical trial of ibudilast to treat recurrent and newly diagnosed glioblastoma

January 13, 2023 Research and Development

Biopharmaceutical company MediciNova has announced that its phase 2 clinical trial to assess MN-166 (ibudilast) for the treatment of recurring …
News

Ajinomoto and Exelixis sign agreement to develop novel ADCs for cancer treatment

January 12, 2023 Research and Development

Ajinomoto Co., a Japanese biotech company providing biopharmaceuticals, has signed a license agreement with Exelixis Inc., an oncology-focused biotech company, …
News

Oramed shares disappointing top-line results from phase 3 trial for type 2 diabetes treatment

January 12, 2023 Research and Development

Clinical stage pharmaceutical company, Oramed Pharmaceuticals, has announced top-line results from its phase 3 randomised, double-blind, placebo-controlled, multicentre trial, which …
News

Alvotech’s golimumab biosimilar phase 1 trial begins

January 12, 2023 Research and Development

Alvotech has announced that it has begun a phase 1 study evaluating the safety, tolerability and pharmacokinetics of its golimumab …
News

AbbVie and Anima collaborate for mRNA biology modulators

January 11, 2023 Research and Development

AbbVie and Amina Biotech have announced their collaboration for the discovery and development of mRNA biology modulators focusing on three …
News

FDA grants approval to third-generation VERO Biotech GENOSYL delivery system

January 11, 2023 Research and Development

The FDA has approved US-based medical equipment supplier VERO Biotech’s new-generation tankless inhaled nitric oxide (iNO) delivery system. This new …
News

Day One Biopharmaceuticals to file NDA for paediatric brain cancer treatment before second half of 2023

January 10, 2023 Research and Development

Day One Biopharmaceuticals is set to ask the FDA for approval for tovorafenib before the summer of 2023. Tovorafenib is …
News

FDA approves Eisai-Biogen’s lecanemab for Alzheimer’s disease

January 9, 2023 Research and Development

The FDA has approved Eisai and Biogen’s experimental antibody treatment lecanemab (also known as Leqembi) for the treatment of mild …
News

Island Pharmaceuticals to begin phase 2 trial for dengue prevention and treatment drug

January 5, 2023 Research and Development

It is possible that Island Pharmaceuticals could begin its phase 2a PEACH clinical trial as soon as January 2023. The …
News

Belharra Therapeutics and Genentech join forces for small molecule medicine development

January 5, 2023 Research and Development

US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small …
News

Biogen and Alcyone Therapeutics enter partnership to develop ThecaFlex DRx system for ASO therapies

January 5, 2023 Research and Development

US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System.   …
News

Rare cancer drug for young patients approved

January 3, 2023 Research and Development

A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …
News

Abiomed receives FDA approval for heart pump clinical trial

December 22, 2022 Research and Development

Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …
News

Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension

December 20, 2022 Research and Development

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …
News

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022 Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025